ARCHIVES
VOL. 7, ISSUE 6 (2021)
Intellectual property rights and the impact of TRIPS agreement with reference to patent law in pharmaceutical areas
Authors
Abhisikta Basu
Abstract
One of the crucial results of the Uruguay Round negotiation came into effect of a new international instrument on Intellectual Property Rights called the Agreement on Trade-Related Aspects of Intellectual Property Rights. The TRIPS Agreement, as it is more famously known, addresses a wide scope of Intellectual Property Rights which incorporates conventional topics like license, copyrights, brand names and modern plans, just as new subject like topographical signs and proprietary advantages. The subject of this Agreement is of incredible significance and is seeing impressive new turns of events and difficulties. At the multilateral levels, negotiations are under way to introduce new provisions, which can be more than what the TRIPS provide for, hence said to be TRIPS-plus. This presented new challenges and opportunities for developing countries like India. India, as a growing economy has considerable stake in knowledge-based industries which can translate into protecting intellectual property in order to encourage research and innovation. Simultaneously, it should be taken into account that the bar of intellectual property protection is not raised so high as to antagonistically influence the imperativeness of a portion of its key assembling areas like pharmaceuticals.
Download
Pages:137-143
How to cite this article:
Abhisikta Basu "Intellectual property rights and the impact of TRIPS agreement with reference to patent law in pharmaceutical areas ". International Journal of Law, Vol 7, Issue 6, 2021, Pages 137-143
Download Author Certificate
Please enter the email address corresponding to this article submission to download your certificate.